Search research articles
Contact Us
Filters
Showing results (131-140 of 166) with videos related to
Page
of 17
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 14, 2018
The hard road to data interpretation: 3 or 6 months of adjuvant chemotherapy for patients with stage III colon cancer?
A Sobrero, A Grothey, T Iveson, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 26, 2009
Clinical and histopathological risk factors to predict sentinel lymph node positivity, disease-free and overall survival in clinical stages I-II AJCC skin melanoma: outcome analysis from a single-institution prospectively collected database
M Mandalà, G L Imberti, D Piazzalunga, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 17, 2010
Intermittent versus continuous chemotherapy in advanced colorectal cancer: a randomised 'GISCAD' trial
R Labianca, A Sobrero, L Isa, et al.
Cancer Detection and Prevention
|
April 2, 1999
Subcutaneous administration of interleukin-2 and interferon-alpha 2b in advanced renal cell carcinoma: long-term results
M C Locatelli, G Facendola, G Pizzocaro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 28, 2002
Specific codon 13 K-ras mutations are predictive of clinical outcome in colorectal cancer patients, whereas codon 12 K-ras mutations are associated with mucinous histotype
V Bazan, M Migliavacca, I Zanna, et al.
British Journal of Cancer
|
April 20, 2001
5-fluorouracil modulated by leucovorin, methotrexate and mitomycin: highly effective, low-cost chemotherapy for advanced colorectal cancer
A Sobrero, A Guglielmi, M Cirillo, et al.
Anticancer Research
|
November 2, 2010
Clinical and molecular determinants of survival in pancreatic cancer patients treated with second-line chemotherapy: results of an Italian/Swiss multicenter survey
A Mancuso, S Sacchetta, P C Saletti, et al.
British Journal of Cancer
|
March 1, 2002
Infusional 5-fluorouracil, cisplatin and mitomycin C in advanced gastric cancer: a low cost effective regimen
S Cascinu, A M Baldelli, V Catalano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 26, 2015
Value of KRAS as prognostic or predictive marker in NSCLC: results from the TAILOR trial
E Rulli, M Marabese, V Torri, et al.
Lancet (London, England)
|
September 12, 1998
Adjuvant portal-vein infusion of fluorouracil and heparin in colorectal cancer: a randomised trial. European Organisation for Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group, the Gruppo Interdisciplinare Valutazione Interventi in Oncologia, and the Japanese Foundation for Cancer Research
P Rougier, T Sahmoud, D Nitti, et al.
Page
of 17
Search research articles
Search
Showing results (131-140 of 166) with videos related to
Sort By:
Page
of 17
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 14, 2018
The hard road to data interpretation: 3 or 6 months of adjuvant chemotherapy for patients with stage III colon cancer?
A Sobrero, A Grothey, T Iveson, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 26, 2009
Clinical and histopathological risk factors to predict sentinel lymph node positivity, disease-free and overall survival in clinical stages I-II AJCC skin melanoma: outcome analysis from a single-institution prospectively collected database
M Mandalà, G L Imberti, D Piazzalunga, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 17, 2010
Intermittent versus continuous chemotherapy in advanced colorectal cancer: a randomised 'GISCAD' trial
R Labianca, A Sobrero, L Isa, et al.
Cancer Detection and Prevention
|
April 2, 1999
Subcutaneous administration of interleukin-2 and interferon-alpha 2b in advanced renal cell carcinoma: long-term results
M C Locatelli, G Facendola, G Pizzocaro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 28, 2002
Specific codon 13 K-ras mutations are predictive of clinical outcome in colorectal cancer patients, whereas codon 12 K-ras mutations are associated with mucinous histotype
V Bazan, M Migliavacca, I Zanna, et al.
British Journal of Cancer
|
April 20, 2001
5-fluorouracil modulated by leucovorin, methotrexate and mitomycin: highly effective, low-cost chemotherapy for advanced colorectal cancer
A Sobrero, A Guglielmi, M Cirillo, et al.
Anticancer Research
|
November 2, 2010
Clinical and molecular determinants of survival in pancreatic cancer patients treated with second-line chemotherapy: results of an Italian/Swiss multicenter survey
A Mancuso, S Sacchetta, P C Saletti, et al.
British Journal of Cancer
|
March 1, 2002
Infusional 5-fluorouracil, cisplatin and mitomycin C in advanced gastric cancer: a low cost effective regimen
S Cascinu, A M Baldelli, V Catalano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 26, 2015
Value of KRAS as prognostic or predictive marker in NSCLC: results from the TAILOR trial
E Rulli, M Marabese, V Torri, et al.
Lancet (London, England)
|
September 12, 1998
Adjuvant portal-vein infusion of fluorouracil and heparin in colorectal cancer: a randomised trial. European Organisation for Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group, the Gruppo Interdisciplinare Valutazione Interventi in Oncologia, and the Japanese Foundation for Cancer Research
P Rougier, T Sahmoud, D Nitti, et al.
Page
of 17